AI could unlock the greatest era of scientific discovery in human history. Getting there depends on what we choose to build, and who we build it with.

Today, a biologist's work is scattered across dozens of disconnected tools, databases, and compute environments. For decades, that fragmentation has been the cost of doing science at speed.

That's starting to change. The pharma companies, biotechs, and research institutions leading the way are putting Claude directly into the hands of their scientists — compressing timelines that used to be measured in weeks into hours, and rethinking what an AI-native research environment can look like.

On June 30th, Anthropic invites you to join virtually us as we share the state of AI in science today, and where it's heading next.

What you’ll experience

• New product innovation demonstrations from Anthropic product leaders
• A first look at new research, built in partnership with research partners
• A customer showcase with leading pharma, biotech, and research institutions sharing outcomes they've seen with Claude

Who should watch

Senior executives at pharma, biotech, and medical device companies shaping AI strategy — including CIOs, CDOs, Chief Scientific Officers, and VPs of R&D, clinical operations, and regulatory affairs. Principal investigators, lab directors, and research leaders at academic and nonprofit institutions. Founders at life sciences and scientific tooling startups.